Acute supplementation with whey protein or collagen does not alter appetite in healthy women: a randomised double-blind and crossover pilot study.
Giovanna M F DuarteKetolly V de FreitasAna C B MariniBruna M GiglioRenata C FernandesPatrícia C B LoboJoão F MotaGustavo Duarte PimentelPublished in: The British journal of nutrition (2021)
Protein quality has an important role in increasing satiety. Evidence suggests that whey protein (WP) provides satiety via gastrointestinal hormone secretion. Hydrolysed collagen supplementation can also stimulate the production of incretins and influence satiety and food intake. Thus, we sought to compare the effect of acute supplementation of WP or hydrolysed collagen on post-intervention appetite and energy consumption. This was a randomised, double-blind, crossover pilot study with ten healthy adult women (22·4 years/old) who were submitted to acute intake (single dose) of a beverage containing WP (40 g of concentrated WP) or hydrolysed collagen (40 g). Subjective appetite ratings (feelings of hunger, desire to eat and full stomach) were measured using the Visual Analog Scale (VAS), energy intake was quantified by ad libitum cheese bread consumption 2 hours after supplementation and blood was collected for leptin and glucose determination. There was no difference between treatment groups in the perception of hunger (P = 0·983), desire to eat (P = 0·326), full stomach feeling (P = 0·567) or food consumption (P = 0·168). Leptin concentrations at 60 min post supplementation were higher when subjects received hydrolysed collagen (P = 0·006). Acute supplementation with hydrolysed collagen increased leptin levels in comparison with WP, but had no effect on appetite measured by feelings of hunger, desire to eat, full stomach feeling (VAS) or energy consumption.
Keyphrases
- double blind
- placebo controlled
- liver failure
- clinical trial
- respiratory failure
- open label
- wound healing
- weight loss
- tissue engineering
- aortic dissection
- drug induced
- study protocol
- body weight
- randomized controlled trial
- phase iii
- phase ii
- protein protein
- polycystic ovary syndrome
- type diabetes
- small molecule
- blood glucose
- pregnancy outcomes
- weight gain
- metabolic syndrome
- risk assessment
- depressive symptoms
- mass spectrometry
- climate change
- replacement therapy